CFGS
SRPT icon

Concourse Financial Group Securities’s Sarepta Therapeutics SRPT Stock Holding History

Concourse Financial Group Securities’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-221
Closed -$25.7K – 1790
2024
Q4 		$25.7K Sell
221
-12
-5% -$1.47K ﹤0.01% 1470
2024
Q3 		$29.1K Sell
233
-8
-3% -$1.11K ﹤0.01% 1402
2024
Q2 		$38.1K Buy
241
+12
+5% +$1.54K ﹤0.01% 1295
2024
Q1 		$29.6K Buy
229
+6
+3% +$735 ﹤0.01% 1389
2023
Q4 		$21.5K Hold
223
– – ﹤0.01% 1468
2023
Q3 		$27K Buy
223
+157
+238% +$17.7K ﹤0.01% 1340
2023
Q2 		$7.56K Hold
66
– – ﹤0.01% 1732
2023
Q1 		$9.1K Buy
+66
New +$8.56K ﹤0.01% 1687
2022
Q4 		– Sell
-66
Closed -$7.65K – 2350
2022
Q3 		$7K Hold
66
– – ﹤0.01% 1580
2022
Q2 		$5K Hold
66
– – ﹤0.01% 1861
2022
Q1 		$5K Sell
66
-1,476
-96% -$113K ﹤0.01% 1873
2021
Q4 		$139K Sell
1,542
-100
-6% -$8.55K 0.01% 863
2021
Q3 		$152K Sell
1,642
-60
-4% -$4.62K 0.01% 823
2021
Q2 		$132K Buy
1,702
+60
+4% +$4.55K 0.01% 866
2021
Q1 		$122K Sell
1,642
-55
-3% -$5.08K 0.01% 854
2020
Q4 		$289K Buy
1,697
+8
+0.5% +$1.19K 0.02% 505
2020
Q3 		$237K Buy
1,689
+247
+17% +$37.5K 0.02% 499
2020
Q2 		$231K Hold
1,442
– – 0.02% 468
2020
Q1 		$141K Buy
1,442
+800
+125% +$91.4K 0.02% 559
2019
Q4 		$83K Hold
642
– – 0.01% 769
2019
Q3 		$48K Sell
642
-31
-5% -$3.66K 0.01% 636
2019
Q2 		$102K Buy
673
+553
+461% +$67.2K 0.01% 653
2019
Q1 		$14K Buy
+120
New +$15.4K ﹤0.01% 1405

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Concourse Financial Group Securities's SRPT Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 221 shares — an estimated $25.7K sold.

Concourse Financial Group Securities first reported a position in SRPT in Q1 2019 and held it in 23 quarters. The position peaked at $289K in Q4 2020. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 221 Sarepta Therapeutics shares in Q1 2025, an estimated $25.7K.
  • Concourse Financial Group Securities first reported a position in Sarepta Therapeutics in Q1 2019 and held it in 23 quarters.
  • Concourse Financial Group Securities's Sarepta Therapeutics position peaked at $289K in Q4 2020.
  • 431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.